Argenica Therapeutics Ltd
ASX:AGN

Watchlist Manager
Argenica Therapeutics Ltd Logo
Argenica Therapeutics Ltd
ASX:AGN
Watchlist
Price: 0.68 AUD -3.55% Market Closed
Market Cap: 87.1m AUD

During the last 3 months Argenica Therapeutics Ltd insiders have not bought any shares, and have not sold any shares. The stock price has increased by 3% over this period (open performance analysis).

The last transaction was made on Aug 14, 2024 by Ms Dianne Margaret Angus (Executive Director / Chief Operating Officer) , who bought 137.5k AUD worth of AGN shares.

Last Transactions:
Ms Dianne Margaret Angus
Executive Director / Chief Operating Officer
AU$+137.5k
Dr Liz Dallimore
Managing Director
AU$+750k
Dr Liz Dallimore
Managing Director
AU$+1.3m
Mr Terrence (Terry) Charles Budge
Non-Executive Director
AU$+181.8k
Mr Terrence (Terry) Charles Budge
Non-Executive Director
AU$+251.4k
Ms Elizabeth (Liddy) Mccall
Non-Executive Director
AU$+150k
Ms Elizabeth (Liddy) Mccall
Non-Executive Director
AU$+251.4k
Geoffrey (Geoff) Pocock
Executive Chairman
AU$+150k
Geoffrey (Geoff) Pocock
Executive Chairman
AU$+211.9k
Liz Dallimore
Chief Executive Officer
AU$+1.1m
Geoffrey (Geoff) Pocock
Executive Chairman
AU$+11.1k
Liz Dallimore
Chief Executive Officer
AU$+4.4k
Geoffrey (Geoff) Pocock
Executive Chairman
AU$+13.5k
Liz Dallimore
Chief Executive Officer
AU$+15.6k
Terrence (Terry) Budge
Non-Executive Director
AU$+20.8k
View All Transactions

During the last 3 months Argenica Therapeutics Ltd insiders have not bought any shares, and have not sold any shares. The stock price has increased by 3% over this period (open performance analysis).

The last transaction was made on Aug 14, 2024 by Ms Dianne Margaret Angus (Executive Director / Chief Operating Officer) , who bought 137.5k AUD worth of AGN shares.

Sold
0-3
months
0 AUD
0
3-6
months
0 AUD
0
6-9
months
0 AUD
0
9-12
months
0 AUD
0
Bought
0-3
months
No Insider Transactions
0
0 AUD
3-6
months
No Insider Transactions
0
0 AUD
6-9
months
4
3m AUD
9-12
months
1
361.9k AUD

Argenica Therapeutics Ltd
Insider Trading Chart

Argenica Therapeutics Ltd
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Argenica Therapeutics Ltd
Last Insider Transactions

Global
Insiders Monitor

Argenica Therapeutics Ltd
Glance View

Market Cap
87.1m AUD
Industry
Pharmaceuticals

Argenica Therapeutics Ltd. provides neuroprotective treatment. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2021-06-11. Argenica’s lead candidate, ARG-007, aims to protect brain cells and reduce cell death following a stroke, and other types of neural injury. Argenica has accumulated a comprehensive body of published pre-clinical studies demonstrating efficacy of ARG-007 in multiple models of stroke and other central nervous system injury models, including stroke, traumatic brain injury and perinatal hypoxia ischaemia.

AGN Intrinsic Value
0.03 AUD
Overvaluation 96%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top